Key result
E-PASS predicts 30-day mortality after periampullary cancer surgery with high discrimination, yielding ~0.98 AUC.
Why the study?
Surgery in periampullary cancers is associated with high morbimortality rates, and multiple scores are used to predict surgical risk without clear correlation data.
Observational (n=58)
No
Effect estimate: AUC 0.982 (95% CI 0.943-1.000)
p-value: p=0.021
In patients undergoing surgery for periampullary cancers, E-PASS and CRS showed excellent discrimination for mortality, while POSSUM and P-POSSUM had the best calibration.
May aid preoperative risk assessment in periampullary cancer surgery; leaves open prospective validation before routine use.
Background: Surgery in periampullary cancers (PAC) is associated with high morbimortality rates. There are multiple scores used to predict surgical risk. This study aims to identify a possible correlation between POSSUM, P-POSSUM, E-PASS, and mE-PASS scores and morbimortality in patients operated on for PAC. Methods: POSSUM, P-POSSUM, E-PASS, and mE-PASS were calculated for patients operated for PAC in Hospital de Braga between 1 January 2011 and 31 August 2021. The calibration and discrimination of scores were analyzed by comparing the predicted mortality and morbidity with the observed one and by evaluating the Receiver Operating Characteristic (ROC) curve, respectively. Results: The study included 58 patients. The most frequent location was the ampulla of Vater (AVC) (43.10%), and the most frequent stage was IIb (48.28%). The postoperative mortality and morbidity observed at 30 days were 3.45% and 37.93%, respectively. P-POSSUM (O:E 0.45), POSSUM (O:E 0.16), and E-PASS (O:E 0.03) overestimated mortality, and mE-PASS underestimated it (O:E 1.89). In most subgroups, both POSSUM scores showed the best calibration. CRS and E-PASS showed the highest discriminative ability for mortality (AUC 0.982). In the pancreatic head carcinoma subgroup, the SSS showed better calibration for morbidity. The operative score had the best discrimination for the CAV subgroup (AUC 0.767) and for stage IIb (AUC 0.900). No scale showed discriminative ability in overall morbidity. Conclusions: POSSUM and P-POSSUM obtained the best calibration regarding subgroup mortality. E-PASS and CRS showed the highest discrimination for mortality, and the operative score showed the greatest discrimination for morbidity in the subgroups.
No takes yet. Share an insight, caveat, or question.
Perestrelo et al. (2025) conducted an observational in Periampullary cancer (n=58). Surgical risk scores (POSSUM, P-POSSUM, E-PASS, mE-PASS) vs. Observed morbidity and mortality was evaluated on 30-day mortality discrimination (E-PASS and Comprehensive Risk Score) (AUC 0.982, 95% CI 0.943-1.000, p=0.021). The E-PASS and Comprehensive Risk Score demonstrated the highest discriminative ability for predicting 30-day mortality in patients operated on for periampullary cancer, yielding an AUC of 0.982.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: